Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach.

• 戸井, 雅和

• Terunuma, Hiroshi

• Deng, Xuewen

• Dewan, Md Zahidunnabi

• Saji, Shigehira

• Kuroi, Katsumasa

• Yamamoto, Naoki

• Toi, Masakazu

抄録

A suggestive case of metastatic disease from breast cancer is reported. The HER-2-positive tumor was refractory to several agents, including anti-HER-2 therapy, trastuzumab, and lapatinib. After re-induction of trastuzumab in combination with activated natural killer (NK) cell injection therapy, tumor markers decreased, and finally a synergistic effect of taxane and capecitabine led to treatment response. This case suggests that multidisciplinary therapy including an immunological approach might be a breakthrough in the treatment of refractory disease.

収録刊行物

• Breast cancer (Tokyo, Japan)

  Breast cancer (Tokyo, Japan) 18 (1), 64-67, 2011-01

  Springer, Part of Springer Science+Business Media

キーワード

• Breast cancer
• Metastasis
• Natural killer cell
• Chemotherapy
• Trastuzumab

詳細情報

• CRID: 1050001201695112832
• NII論文ID: 10027894715
• NII書誌ID: AA1103354X
• ISSN: 13406868
• HANDLE: 2433/138089
• Web Site: https://search.jamas.or.jp/link/ui/2011255097
• 本文言語コード: en
• 資料種別: journal article
• データソース種別:
  • IRDB
  • CiNii Articles